Caplight Directory>Investors>KHAN Technology Transfer Fund II>Khanu


KHAN Technology Transfer Fund II

KHAN Technology Transfer Fund II

Dortmundkhanu.de

Overview

KHAN Technology Transfer Fund II is an early-stage life sciences venture fund that focuses on creating value through cooperative drug development partnerships with academic innovators in Europe, targeting first-in-class therapies for markets with a high unmet medical need.

Year Founded

2025

Portfolio Companies

2

Website

khanu.de

Investments

CompanyDateStageLead
iDEL TherapeuticsMar 2026SeedCo-investor
iDEL TherapeuticsMar 2026SeedCo-investor
KyDo TherapeuticsSep 2025SeedCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersDortmund
Year Founded2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.